• Investment includes new advanced manufacturing and packaging technologies and a new state-of-the-art distribution facility to scale the Company's U.S. Vision operations, enhance supply chain resilience, and meet the needs of more than 40 million patients
  • Investment is part of the Company's ongoing $55 billion commitment to U.S. manufacturing, research and development, and technology through early 2029
  • Building on more than 40 years of leadership in Florida, the investment supports 3,500 Jacksonville employees and strengthens Johnson & Johnson's $6 billion annual economic impact across the state